Vergoeding 2020-2024 voor ATC-subgroep J01 : Antibacteriele middelen voor systemisch gebruik
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| J01A Tetracyclines | 2.484.400 | 3.904.100 | 5.213.400 | 5.426.200 | 6.312.800 |
| J01B Amfenicolen | . | . | 11 | . | 4 |
| J01C Betalactam-antibiotica penicillines | 11.340.000 | 13.651.700 | 16.828.300 | 19.437.300 | 21.422.600 |
| J01D Overige betalactam-antibiotica | 5.537.000 | 6.000.400 | 6.918.400 | 7.971.000 | 9.379.200 |
| J01E Sulfonamiden en trimethoprim | 1.368.300 | 1.410.800 | 1.506.600 | 1.488.700 | 1.625.100 |
| J01F Macroliden lincosamiden en streptograminen | 4.242.700 | 3.167.100 | 3.635.900 | 5.696.300 | 7.650.100 |
| J01G Aminoglycosiden | 4.165.500 | 4.165.800 | 3.872.800 | 3.674.200 | 3.852.300 |
| J01M Chinolonen | 2.415.300 | 2.358.500 | 2.376.200 | 2.635.600 | 3.273.100 |
| J01X Overige antibacteriele middelen | 10.193.400 | 10.836.600 | 10.788.800 | 10.819.500 | 11.419.600 |
| Totaal | 41.746.600 | 45.495.000 | 51.140.411 | 57.148.800 | 64.934.804 |